Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area

British Journal of Cancer

Volumn 89, Issue 4, 2003, Pages 681-686

  Chen, I H ^a   Chang, J T ^a   Liao, C T ^a   Wang, H M ^a   Hsieh, L L ^a,b   Cheng, A J ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Betel quid; EGFR; Her 2; Oral cancer; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BETEL NUT; CANCER STAGING; CANCER SURVIVAL; ENZYME IMMUNOASSAY; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; SMOKING; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ARECA; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PLANTS, MEDICINAL; PREVALENCE; PROGNOSIS; QUESTIONNAIRES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TAIWAN; TUMOR MARKERS, BIOLOGICAL;

EID: 0041733629     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601171     Document Type: Article

References (34)

1. Bei R, Pompa G, Vitolo D, Moriconi E, Ciocci L, Quaranta M, Frati L, Kraus MH, Muraro R (2001) Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma. J Pathol 195: 343-348
2. Chen CH (1987) An epidemiological study of oral squamous cell carcinoma in southern Taiwan. J Formosan Dent Assoc 10: 268-274
3. Chong KM (1966) Betel nut chewing and mouth cancer in Taiwan. Observation of the oral mucosa in the betel nut chewers. J Formosan Med Assoc 65: 79-85
4. Christensen ME, Engbaek F, Therkildsen MH, Bretlau P, Nexo E (1995) A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Br J Cancer 72: 1487-1493
5. Clayman GL, Lippman SM, Laramore GE, Hong WK (1996) Head and neck cancer. In: Cancer Medicine, Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum R (eds) pp 1645-1709. Philadelphia: Williams and Wilkins
6. Colomer R, Shamon LA, Tsai MS, Lupu R (2001) Herceptin: from the bench to the clinic. Cancer Invest 19: 49-56
7. Contreras DN, Cohos E, Lox CD (2002) Evaluation of the circulating fraction of the HER-2/neu oncogene in patients with cervical cancer. Eur J Gynaecol Oncol 23: 491-495
8. Daftary DK, Murti PR, Bhonsle RR, Gupta PC, Mehta FS, Pindborg JJ (1991) Risk factors and risk markers for oral cancers in high risk areas of the world. In: Oral Cancer: Detection of Patients and Lesions at Risk, Johnson NW (ed) pp 29-63. Cambridge: Cambridge University Press
9. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin L, Yarbro JW (1998) AJCC Cancer Staging Manual, 5th edn. Lippincott: Williams Wilkins
10. Franceschi S, Talamini R, Barra S (1990) Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 50: 6502-6507
11. Hsieh LL, Wang PF, Chen IH, Liao CT, Wang HM, Chen MC, Chang JTC, Cheng AJ (2001) Characteristics of mutations in the p53 genes in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis 22: 1497-1503
12. Johnson NW (1991) A global view of the epidemiology of oral cancer. In: Oral Cancer: Detection of Patients and Lesions at Risk, Johnson NW (ed) pp 3-26. Cambridge: Cambridge University Press
13. Klijn JG, Berns PM, Schmitz PI, Foekens JA (1992) The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5253 patients. Endocr Rev 13: 3-17
14. Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, Haffty BG (2002) Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. Clin Cancer Res 8: 540-548
15. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC (1995) Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 24: 450-453
16. Li X, Lee NK, Ye YW, Waber PG, Schweitzer C, Cheng QC, Nisen PD (1994) Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 86: 1524-1529
17. Olayioye MA, Neve RM, Lane HA, Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19: 3159-3167
18. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics. CA Cancer J Clin 46: 5-27
19. Pfeiffer P, Nexo E, Bentzen SM, Clausen PP, Andersen K, Rose C (1998) Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis. Br J Cancer 78: 96-99
20. Robert F, Ezekiel MP, Spencer SA, Meredith RF, Bonner JA, Khazaeli MB, Saleh MN, Carey D, LoBuglio AF, Wheeler RH, Cooper MR, Waksal HW (2002) Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol 19: 3234-3243
21. Salomon DS, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19: 183-232
22. Shanmugaratnam K (1991) Histological typing of tumours of the upper respiratory tract and ear. International Histological Classification of Tumours, 2nd edn. Berlin: Spring-Verlag
23. Shin DM, Donato NJ, Perez-Soler R, Shin HJC, Wu JY, Zhang P, Lawhorn K, Khuri FR, Glisson BS, Myers J, Clayman G, Pfister D, Falcey J, Waksai H, Mendelsohn J, Hong WK (2001) Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Clin Cancer Res 7: 1204-1213
24. Simon MA (2000) Receptor tyrosine kinases: specific outcomes from general signals. Cell 103: 13-15
25. Slaughter DP, Southwick HW, Smejkal W (1953) 'Field cancerization' in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 6: 963-968
26. Storkel S, Reichert T, Reiffen KA, Wagner W (1993) EGFR and PCNA expression in oral squamous cell carcinomas-a valuable tool in estimating the patient's prognosis. Eur J Cancer B Oral Oncol 29B: 273-277
27. Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC, Carey TE (1994) Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer 9: 192-206
28. Vikram B (1994) Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 110: 564-565
29. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532
30. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993) Head and neck cancer. N Eng J Med 328: 184-194
31. Werkmeister R, Brandt B, Joos U (2000) Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas. Oral Oncol 36: 100-105
32. Widschwendter A, Tonko-Geymayer S, Welte T, Daxenbichler G, Marth C, Doppler W (2002) Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res 8: 3065-3074
33. Wong DYK, Chang KW, Chen CF, Chang RCS (1990) Characterization of two new cell lines-OC1 and OC2. J Oral Maxilofac Surg 48: 385-390
34. Xia W, Lau YK, Zhang HZ, Xiao FY, Johnston DA, Liu AR, Li L, Katz RL, Hung MC (1999) Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 5: 4164-4174